Press releases

Advanced Search
  • May 5, 2014
    Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment

    SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...

  • May 2, 2014

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...

  • May 1, 2014
    - Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...

  • Apr 24, 2014
    Also Introduces the pink Achieve® Breast Biopsy Device

    SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...

  • Apr 24, 2014
    Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings

    BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...